Market Overview

UPDATE: Jefferies Raises PT on Cigna Following Solid 1Q13 EPS

Related CI
Trump, House Republicans Seek Delay In Healthcare Ruling - Because They're Afraid They'll Win
Wall Street's M&A Chatter From February 14
CIGNA declares $0.04 dividend (Seeking Alpha)

In a report published Friday, Jefferies analyst David Windley reiterated a Buy rating on Cigna Corporation (NYSE: CI), and raised the price target from $74.00 to $78.00.

In the report, Windley noted, “CI's fundamentals are continuing to advance well. The company's solid 21% 1Q13 EPS beat and 2.5% EPS guidance raise start 2013 off nicely. Like others, management has eased off its confidence in growing 2014 earnings due to the MA rate cuts. They will reassess and provide an update later in the year. We are also still awaiting the PBM decision.”

Cigna Corporation closed on Thursday at $68.07.

Latest Ratings for CI

Feb 2017RBC CapitalUpgradesSector PerformOutperform
Jan 2017PiperJaffrayInitiates Coverage OnOverweight
Sep 2016Evercore ISI GroupInitiates Coverage onHold

View More Analyst Ratings for CI
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Analyst Ratings


Related Articles (CI)

View Comments and Join the Discussion!